Membrane Trafficking of G Protein-Coupled Receptors

Annual Review of Pharmacology and Toxicology

Volumn 44, Issue , 2004, Pages 559-609

  Tan, Christopher M ^a   Brady, Ashley E ^a   Nickols, Hilary Highfield ^a   Wang, Qin ^a   Limbird, Lee E ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Agonist elicited endocytosis; Protein protein interactions

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; 4 AMINOBUTYRIC ACID B RECEPTOR; 4 AMINOBUTYRIC ACID C RECEPTOR; ALPHA 1B ADRENERGIC RECEPTOR; ALPHA 2 ADRENERGIC RECEPTOR; ALPHA 2A ADRENERGIC RECEPTOR; ALPHA 2B ADRENERGIC RECEPTOR; ALPHA 2C ADRENERGIC RECEPTOR; ANGIOTENSIN 2 RECEPTOR; BETA 2 ADRENERGIC RECEPTOR; CALCITONIN RECEPTOR; CALCIUM SENSING RECEPTOR; DOPAMINE 4 RECEPTOR; FOLLITROPIN RECEPTOR; G PROTEIN COUPLED RECEPTOR; LUTEINIZING HORMONE RECEPTOR; METABOTROPIC RECEPTOR 1; METABOTROPIC RECEPTOR 2; METABOTROPIC RECEPTOR 3; METABOTROPIC RECEPTOR 5; MUSCARINIC M2 RECEPTOR; MUSCARINIC M3 RECEPTOR; PARATHYROID HORMONE RECEPTOR; THYROTROPIN RECEPTOR;

CELL COMPARTMENTALIZATION; CELL SURFACE; HUMAN; HUMAN CELL; MEMBRANE TRANSPORT; PRIORITY JOURNAL; PROTEIN INTERACTION; PROTEIN LOCALIZATION; PROTEIN STABILITY; PROTEIN TRANSPORT; RECEPTOR DOWN REGULATION; RECEPTOR UPREGULATION; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; CELL MEMBRANE; DIABETES INSIPIDUS, NEPHROGENIC; HUMANS; HYPOGONADISM; MEMBRANE TRANSPORT PROTEINS; MOLECULAR CHAPERONES; RECEPTORS, G-PROTEIN-COUPLED; RETINITIS PIGMENTOSA; SIGNAL TRANSDUCTION;

EID: 1342344805     PISSN: 03621642     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.pharmtox.44.101802.121558     Document Type: Review

References (283)

1. Pierce KL, Maudsley S, Daaka Y, Luttrell LM, Lefkowitz RJ. 2000. Role of endocytosis in the activation of the extracellular signal-regulated kinase cascade by sequestering and nonsequestering G protein-coupled receptors. Proc. Natl. Acad. Sci. USA 97:1489-94
2. Humphries P, Kenna P, Farrar GJ. 1992. On the molecular genetics of retinitis pigmentosa. Science 256:804-8
3. Oksche A, Rosenthal W. 1998. The molecular basis of nephrogenic diabetes insipidus. J. Mol. Med. 76:326-37
4. Layman LC, Cohen DP, Jin M, Xie J, Li Z, et al. 1998. Mutations in gonadotropin-releasing hormone receptor gene cause hypogonadotropic hypogonadism. Nat. Genet. 18:14-15
5. McPherson GA, Summers RJ. 1983. Evidence from binding studies for alpha 2-adrenoceptors directly associated with glomeruli from rat kidney. Eur. J. Pharmacol. 90:333-41
6. Matsushima Y, Akabane S, Kawamura M, Ito K. 1987. Distribution of alpha 1- and alpha 2-adrenoceptors in brush border and basolateral membranes from rat kidney cortical tubules. Jpn. J. Pharmacol. 45:284-87
7. McPherson GA, Summers RJ. 1982. Localisation of [3H]clonidine binding to membranes from guinea pig renal tubules. Biochem. Pharmacol. 31:583-87
8. Simons K, Fuller SD. 1985. Cell surface polarity in epithelia. Annu. Rev. Cell Biol. 1:243-88
9. Handler JS, Perkins FM, Johnson JP. 1980. Studies of renal cell function using cell culture techniques. Am. J. Physiol. Renal Physiol. 238:F1-9
10. Drubin DG, Nelson WJ. 1996. Origins of cell polarity. Cell 84:335-44
11. Matter ML, Ginsberg MH, Ramos JW. 2001. Identification of cell signaling molecules by expression cloning. Science STKE 2001:L9
12. Keefer JR, Kennedy ME, Limbird LE. 1994. Unique structural features important for stabilization versus polarization of the alpha 2A-adrenergic receptor on the basolateral membrane of Madin-Darby canine kidney cells. J. Biol. Chem. 269:16425-32
13. Wozniak M, Limbird LE. 1996. The three alpha 2-adrenergic receptor subtypes achieve basolateral localization in Madin-Darby canine kidney II cells via different targeting mechanisms. J. Biol. Chem. 271:5017-24
14. Keefer JR, Limbird LE. 1993. The alpha 2A-adrenergic receptor is targeted directly to the basolateral membrane domain of Madin-Darby canine kidney cells independent of coupling to pertussis toxin-sensitive GTP-binding proteins. J. Biol. Chem. 268: 11340-47
15. Saunders C, Keefer JR, Bonner CA, Limbird LE. 1998. Targeting of G protein-coupled receptors to the basolateral surface of polarized renal epithelial cells involves multiple, non-contiguous structural signals. J. Biol. Chem. 273:24196-206
16. von Zastrow M, Link R, Daunt D, Barsh G, Kobilka B. 1993. Subtype-specific differences in the intracellular sorting of G protein-coupled receptors. J. Biol. Chem. 268:763-66
17. Taraviras S, Olli-Lahdesmaki T, Lymperopoulos A, Charitonidou D, Mavroidis M, et al. 2002. Subtype-specific neuronal differentiation of PC12 cells transfected with alpha2-adrenergic receptors. Eur. J. Cell Biol. 81:363-74
18. Olli-Lahdesmaki T, Kallio J, Scheinin M. 1999. Receptor subtype-induced targeting and subtype-specific internalization of human alpha(2)-adrenoceptors in PC12 cells. J. Neurosci. 19:9281-88
19. Richman JG, Regan JW. 1998. Alpha 2-adrenergic receptors increase cell migration and decrease F-actin labeling in rat aortic smooth muscle cells. Am. J. Physiol. Cell Physiol. 274:C654-62
20. Daunt DA, Hurt C, Hein L, Kallio J, Feng F, Kobilka BK. 1997. Subtype-specific intracellular trafficking of alpha2-adrenergic receptors. Mol. Pharmacol. 51:711-20
21. Rosen MI, McMahon TJ, Hameedi FA, Pearsall HR, Woods SW, et al. 1996. Effect of clonidine pretreatment on naloxone-precipitated opiate withdrawal. J. Pharmacol. Exp. Ther. 276: 1128-35
22. Hurt CM, Feng FY, Kobilka B. 2000. Cell-type specific targeting of the alpha 2c-adrenoceptor. Evidence for the organization of receptor microdomains during neuronal differentiation of PC12 cells. J. Biol. Chem. 275:35424-31
23. Morrison DK. 2001. KSR: aMAPK scaffold of the Ras pathway? J. Cell Sci. 114:1609-12
24. Chotani MA, Flavahan S, Mitra S, Daunt D, Flavahan NA. 2000. Silent alpha(2C)-adrenergic receptors enable cold-induced vasoconstriction in cutaneous arteries. Am. J. Physiol. Heart Circ. Physiol. 278:H1075-83
25. Brady AE, Wang Q, Colbran RJ, Allen PB, Greengard P, Limbird LE. 2003. Spinophilin stabilizes cell surface expression of alpha 2B-adrenergic receptors. J. Biol. Chem. 278:32405-12
26. Bonifacino JS, Dell'Angelica EC. 1999. Molecular bases for the recognition of tyrosine-based sorting signals. J. Cell Biol. 145:923-26
27. Stephens DJ, Banting G. 1999. Direct interaction of the trans-Golgi network membrane protein, TGN38, with the F-actin binding protein, neurabin. J. Biol. Chem. 274:30080-86
28. Madrid R, Le Maout S, Barrault MB, Janvier K, Benichou S, Merot J. 2001. Polarized trafficking and surface expression of the AQP4 water channel are coordinated by serial and regulated interactions with different clathrin-adaptor complexes. EMBO J. 20:7008-21
29. Ohno H, Tomemori T, Nakatsu F, Okazaki Y, Aguilar RC, et al. 1999. MulB, a novel adaptor medium chain expressed in polarized epithelial cells. FEBS Lett. 449:215-20
30. Folsch H, Ohno H, Bonifacino JS, Mellman I. 1999. A novel clathrin adaptor complex mediates basolateral targeting in polarized epithelial cells. Cell 99:189-98
31. Chen WJ, Goldstein JL, Brown MS. 1990. NPXY, a sequence often found in cytoplasmic tails, is required for coated pit-mediated internalization of the low density lipoprotein receptor. J. Biol. Chem. 265:3116-23
32. Hsu D, Knudson PE, Zapf A, Rolband GC, Olefsky JM. 1994. NPXY motif in the insulin-like growth factor-I receptor is required for efficient ligand-mediated receptor internalization and biological signaling. Endocrinology 134:744-50
33. Zeng WZ, Babich V, Ortega B, Quigley R, White SJ, et al. 2002. Evidence for endocytosis of ROMK potassium channel via clathrin-coated vesicles. Am. J. Physiol. Renal Physiol. 283:F630-39
34. Matter K, Hunziker W, Mellman I. 1992. Basolateral sorting of LDL receptor in MDCK cells: the cytoplasmic domain contains two tyrosine-dependent targeting determinants. Cell 71:741-53
35. Collawn JF, Stangel M, Kuhn LA, Esekogwu V, Jing SQ, et al. 1990. Transferrin receptor internalization sequence YXRF implicates a tight turn as the structural recognition motif for endocytosis. Cell 63:1061-72
36. a. Slice LW, Wong HC, Sternini C, Grady EF, Bunnett NW, Walsh JH. 1994. The conserved NPXnY motif present in the gastrin-releasing peptide receptor is not a general sequestration sequence. J. Biol. Chem. 269(34):21755-61
37. Hukovic N, Panetta R, Kumar U, Rocheville M, Patel YC. 1998. The cytoplasmic tail of the human somatostatin receptor type 5 is crucial for interaction with adenylyl cyclase and in mediating desensitization and internalization. J. Biol. Chem. 273:21416-22
38. Feng W, Song ZH. 2001. Functional roles of the tyrosine within the NP(X)(n)Y motif and the cysteines in the C-terminal juxtamembrane region of the CB2 cannabinoid receptor. FEBS Lett. 501:166-70
39. Chen Z, Dupre DJ, Le Gouill C, Rola-Pleszczynski M, Stankova J. 2002. Agonist-induced internalization of the platelet-activating factor receptor is dependent on arrestins but independent of G-protein activation. Role of the C terminus and the (D/N)PXXY motif. J. Biol. Chem. 277:7356-62
40. Wang J, Zheng J, Anderson JL, Toews ML. 1997. A mutation in the hamster alpha1B-adrenergic receptor that differentiates two steps in the pathway of receptor internalization. Mol. Pharmacol. 52:306-13.
41. Laporte SA, Servant G, Richard DE, Escher E, Guillemette G, Leduc R. 1996. The tyrosine within the NPXnY motif of the human angiotensin II type 1 receptor is involved in mediating signal transduction but is not essential for internalization. Mol. Pharmacol. 49:89-95
42. Barak LS, Tiberi M, Freedman NJ, Kwatra MM, Lefkowitz RJ, Caron MG. 1994. A highly conserved tyrosine residue in G protein-coupled receptors is required for agonist-mediated beta 2-adrenergic receptor sequestration. J. Biol. Chem. 269:2790-95
43. Gabilondo AM, Krasel C, Lohse MJ. 1996. Mutations of Tyr326 in the beta 2-adrenoceptor disrupt multiple receptor functions. Eur. J. Pharmacol. 307:243-50
44. Bohm SK, Khitin LM, Smeekens SP, Grady EF, Payan DG, Bunnett NW. 1997. Identification of potential tyrosine-containing endocytic motifs in the carboxyl-tail and seventh transmembrane domain of the neurokinin 1 receptor. J. Biol. Chem. 272:2363-72
45. Haft CR, Klausner RD, Taylor SI. 1994. Involvement of dileucine motifs in the internalization and degradation of the insulin receptor. J. Biol. Chem. 269:26286-94
46. Verhey KJ, Yeh JI, Birnbaum MJ. 1995. Distinct signals in the GLUT4 glucose transporter for internalization and for targeting to an insulin-responsive compartment. J. Cell Biol. 130:1071-79
47. Verhey KJ, Birnbaum MJ. 1994. A Leu-Leu sequence is essential for COOH-terminal targeting signal of GLUT4 glucose transporter in fibroblasts. J. Biol. Chem. 269:2353-56
48. Miranda KC, Khromykh T, Christy P, Le TL, Gottardi CJ, et al. 2001. A dileucine motif targets E-cadherin to the basolateral cell surface in Madin-Darby canine kidney LLC-PK1 epithelial cells. J. Biol. Chem. 276:22565-72
49. Hunziker W, Fumey C. 1994. A dileucine motif mediates endocytosis and basolateral sorting of macrophage IgG Fc receptors in MDCK cells. EMBO J. 13:2963-67
50. Schulein R, Hermosilla R, Oksche A, Dehe M, Wiesner B, et al. 1998. A dileucine sequence an upstream glutamate residue in the intracellular carboxyl terminus of the vasopressin V2 receptor ate are essential for cell surface transport in COS.M6 cells. Mol. Pharmacol. 54:525-35
51. Sadeghi H, Robertson GL, Bichet DG, Innamorati G, Birnbaumer M. 1997. Biochemical basis of partial nephrogenic diabetes insipidus phenotypes. Mol. Endocrinol. 11:1806-13
52. Oksche A, Dehe M, Schulein R, Wiesner B, Rosenthal W. 1998. Folding and cell surface expression of the vasopressin V2 receptor: requirement of the intracellular C-terminus. FEBS Lett. 424:57-62
53. Schulein R, Lorenz D, Oksche A, Wiesner B, Hermosilla R, et al. 1998. Polarized cell surface expression of the green fluorescent protein-tagged vasopressin V2 receptor in Madin Darby canine kidney cells. FEBS Lett. 441:170-76
54. Rodriguez MC, Xie YB, Wang H, Collison K, Segaloff DL. 1992. Effects of truncations of the cytoplasmic tail of the luteinizing hormone/chorionic gonadotropin receptor on receptor-mediated hormone internalization. Mol. Endocrinol. 6:327-36
55. a. Orsini MJ, Parent J-L, Nundell SJ, Marchese A, Benovic JL. 1999. Trafficking of the HIV coreceptor CXCR4: role of arrestins and identification of residues in the C-terminal tail that mediate internalization. J. Biol. Chem. 275:25876
56. Gabilondo AM, Hegler J, Krasel C, Boivin-Jahns V, Hein L, Lohse MJ. 1997. A dileucine motif in the C terminus of the beta2-adrenergic receptor is involved in receptor internalization. Proc. Natl. Acad. Sci. USA 94:12285-90
57. Preisser L, Ancellin N, Michaelis L, Creminon C, Morel A, Corman B. 1999. Role of the carboxyl-terminal region, di-leucine motif and cysteine residues in signalling and internalization of vasopressin V1a receptor. FEBS Lett. 460:303-8
58. Bonifacino JS, Traub LM. 2003. Signals for sorting of transmembrane proteins to endosomes and lysosomes. Annu. Rev. Biochem. 72:395-447
59. Bermak JC, Li M, Bullock C, Zhou QY. 2001. Regulation of transport of the dopamine D1 receptor by a new membrane-associated ER protein. Nat. Cell Biol. 3:492-98
60. Leclerc PC, Auger-Messier M, Lanctot PM, Escher E, Leduc R, Guillemette G. 2002. A polyaromatic caveolin-binding-like motif in the cytoplasmic tail of the type 1 receptor for angiotensin II plays an important role in receptor trafficking and signaling. Endocrinology 143:4702-10
61. Venkatesan S, Petrovic A, Locati M, Kim YO, Weissman D, Murphy PM. 2001. A membrane-proximal basic domain and cysteine cluster in the C-terminal tail of CCR5 constitute a bipartite motif critical for cell surface expression. J. Biol. Chem. 276:40133-45
62. Chan WY, Soloviev MM, Ciruela F, McIlhinney RA. 2001. Molecular determinants of metabotropic glutamate receptor 1B trafficking. Mol. Cell Neurosci. 17:577-88
63. Francesconi A, Duvoisin RM. 2002. Alternative splicing unmasks dendritic and axonal targeting signals in metabotropic glutamate receptor 1. J Neurosci. 22: 2196-205
64. Tanabe Y, Masu M, Ishii T, Shigemoto R, Nakanishi S. 1992. A family of metabotropic glutamate receptors. Neuron 8:169-79
65. Hermosilla R, Schulein R. 2001. Sorting functions of the individual cytoplasmic domains of the G protein-coupled vasopressin V(2) receptor in Madin Darby canine kidney epithelial cells. Mol. Pharmacol. 60:1031-39
66. Beau I, Groyer-Picard MT, Le Bivic A, Vannier B, Loosfelt H, et al. 1998. The basolateral localization signal of the follicle-stimulating hormone receptor. J. Biol. Chem. 273:18610-16
67. Nadler LS, Kumar G, Nathanson NM. 2001. Identification of a basolateral sorting signal for the M3 muscarinic acetylcholine receptor in Madin-Darby canine kidney cells. J. Biol. Chem. 276:10539-47
68. Saunders C, Keefer JR, Kennedy AP, Wells JN, Limbird LE. 1996. Receptors coupled to pertussis toxin-sensitive G-proteins traffic to opposite surfaces in Madin-Darby canine kidney cells. Al adenosine receptors achieve apical and alpha 2A adrenergic receptors achieve basolateral localization. J. Biol. Chem. 271:995-1002
69. Chuang JZ, Sung CH. 1998. The cytoplasmic tail of rhodopsin acts as a novel apical sorting signal in polarized MDCK cells. J. Cell Biol. 142:1245-56
70. Jolimay N, Franck L, Langlois X, Hamon M, Darmon M. 2000. Dominant role of the cytosolic C-terminal domain of the rat 5-HT1B receptor in axonalapical targeting. J. Neurosci. 20:9111-18
71. Stowell JN, Craig AM. 1999. Axon/ dendrite targeting of metabotropic glutamate receptors by their cytoplasmic carboxy-terminal domains. Neuron 22:525-36
72. Sparks AB, Hoffman NG, McConnell SJ, Fowlkes DM, Kay BK. 1996. Cloning of ligand targets: systematic isolation of SH3 domain-containing proteins. Nat. Biotechnol. 14:741-44
73. Oldenhof J, Vickery R, Anafi M, Oak J, Ray A, et al. 1998. SH3 binding domains in the dopamine D4 receptor. Biochemistry 37:15726-36
74. Tang Y, Hu LA, Miller WE, Ringstad N, Hall RA, et al. 1999. Identification of the endophilins (SH3p4/p8/p13) as novel binding partners for the beta1-adrenergic receptor. Proc. Natl. Acad. Sci USA 96:12559-64
75. Bouvier M. 2001. Oligomerization of G-protein-coupled transmitter receptors. Nat. Rev. Neurosci. 2:274-86
76. George SR, O'Dowd BF, Lee SP. 2002. G-protein-coupled receptor oligomerization and its potential for drug discovery. Nat. Rev. Drug Discov. 1:808-20
77. Jordan BA, Trapaidze N, Gomes I, Nivarthi R, Devi LA. 2001. Oligomerization of opioid receptors with beta 2-adrenergic receptors: a role in trafficking and mitogen-activated protein kinase activation. Proc. Natl. Acad. Sci USA 98:343-48
78. Jones KA, Borowsky B, Tamm JA, Craig DA, Durkin MM, et al. 1998. GABA(B) receptors function as a heteromeric assembly of the subunits GABA-(B)R1 GABA(B)R2. Nature 396:674-79
79. Kaupmann K, Malitschek B, Schuler V, Heid J, Froestl W, et al. 1998. GABA(B)-receptor subtypes assemble into functional heteromeric complexes. Nature 396:683-87
80. Couve A, Filippov AK, Connolly CN, Bettler B, Brown DA, Moss SJ. 1998. Intracellular retention of recombinant GABA(B) receptors. J. Biol. Chem. 273: 26361-67
81. White JH, Wise A, Main MJ, Green A, Fraser NJ, et al. 1998. Heterodimerization is required for the formation of a functional GABA(B) receptor. Nature 396:679-82
82. Martin SC, Russek SJ, Farb DH. 1999. Molecular identification of the human GABABR2: cell surface expression and coupling to adenylyl cyclase in the absence of GABABR1. Mol. Cell Neurosci. 13:180-91
83. Kuner R, Kohr G, Grunewald S, Eisenhardt G, Bach A, Kornau HC. 1999. Role of heteromer formation in GABAB receptor function. Science 283:74-77
84. Belley M, Sullivan R, Reeves A, Evans J, O'Neill G, Ng GY. 1999. Synthesis of the nanomolar photoaffinity GABA(B) receptor ligand CGP 71872 reveals diversity in the tissue distribution of GABA(B) receptor forms. Bioorg. Med. Chem. 7:2697-704
85. Lupas A. 1996. Coiled coils: new structures new functions. Trends Biochem. Sci. 21:375-82
86. Margeta-Mitrovic M, Jan YN, Jan LY. 2000. A trafficking checkpoint controls GABA(B) receptor heterodimerization. Neuron 27:97-106
87. Calver AR, Robbins MJ, Cosio C, Rice SQ, Babbs AJ, et al. 2001. The C-terminal domains of the GABAB receptor subunits mediate intracellular trafficking but are not required for receptor signaling. J. Neurosci. 21:1203-10
88. Margeta-Mitrovic M, Jan YN, Jan LY. 2001. Ligand-induced signal transduction within heterodimeric GABA(B) receptor. Proc. Natl. Acad. Sci. USA 98:14643-48
89. Adler E, Hoon MA, Mueller KL, Chandrashekar J, Ryba NJ, Zuker CS. 2000. A novel family of mammalian taste receptors. Cell 100:693-702
90. Nelson G, Chandrashekar J, Hoon MA, Feng L, Zhao G, et al. 2002. An amino-acid taste receptor. Nature 416:199-202
91. Nelson G, Hoon MA, Chandrashekar J, Zhang Y, Ryba NJ, Zuker CS. 2001. Mammalian sweet taste receptors. Cell 106:381-90
92. Max M, Shanker YG, Huang L, Rong M, Liu Z, et al. 2001. Tas1r3, encoding a new candidate taste receptor, is allelic to the sweet responsiveness locus Sac. Nat. Genet. 28:58-63
93. Terrillon S, Durroux T, Mouillac B, Breit A, Ayoub MA, et al. 2003. Oxytocin vasopressin V1a and V2 receptors form constitutive homo- and heterodimers during biosynthesis. Mol. Endocrinol. 17:677-91
94. Zhu X, Wess J. 1998. Truncated V2 vasopressin receptors as negative regulators of wild-type V2 receptor function. Biochemistry 37:15773-84
95. Saliba RS, Munro PM, Luthert PJ, Cheetham ME. 2002. The cellular fate of mutant rhodopsin: quality control, degradation and aggresome formation. J. Cell Sci. 115:2907-18
96. Grosse R, Schoneberg T, Schultz G, Gudermann T. 1997. Inhibition of gonadotropin-releasing hormone receptor signaling by expression of a splice variant of the human receptor. Mol. Endocrinol. 11:1305-18
97. Pearce SH, Bai M, Quinn SJ, Kifor O, Brown EM, Thakker RV. 1996. Functional characterization of calcium-sensing receptor mutations expressed in human embryonic kidney cells. J. Clin. Invest. 98:1860-66
98. Schwarz DA, Barry G, Eliasof SD, Petroski RE, Conlon PJ, Maki RA. 2000. Characterization of gamma-aminobutyric acid receptor GABAB(1e), a GABAB(1) splice variant encoding a truncated receptor. J. Biol. Chem. 275:32174-81
99. Benkirane M, Jin DY, Chun RF, Koup RA, Jeang KT. 1997. Mechanism of transdominant inhibition of CCR5-mediated HIV-1 infection by ccr5delta32. J. Biol. Chem. 272:30603-6
100. Karpa KD, Lin R, Kabbani N, Levenson R. 2000. The dopamine D3 receptor interacts with itself and the truncated D3 splice variant d3nf: D3-D3nf interaction causes mislocalization of D3 receptors. Mol. Pharmacol. 58:677-83
101. Jordan BA, Devi LA. 1999. G-protein-coupled receptor heterodimerization modulates receptor function. Nature 399:697-700
102. Gomes I, Jordan BA, Gupta A, Trapaidze N, Nagy V, Devi LA. 2000. Heterodimerization of mu and delta opioid receptors: a role in opiate synergy. J. Neurosci. 20:RC110
103. Rocheville M, Lange DC, Kumar U, Patel SC, Patel RC, Patel YC. 2000. Receptors for dopamine and somatostatin: formation of hetero-oligomers with enhanced functional activity. Science 288:154-57
104. Scarselli M, Novi F, Schallmach E, Lin R, Baragli A, et al. 2001. D2/D3 dopamine receptor heterodimers exhibit unique functional properties. J. Biol. Chem. 276:30308-14
105. Chiacchio S, Scarselli M, Armogida M, Maggio R. 2000. Pharmacological evidence of muscarinic receptor heterodimerization. Pharm. Acta Helv. 74: 315-26
106. Pfeiffer M, Koch T, Schroder H, Laugsch M, Hollt V, Schulz S. 2002. Heterodimerization of somatostatin and opioid receptors cross-modulates phosphorylation, internalization, and desensitization. J. Biol. Chem. 277:19762-72
107. Xu J, He J, Castleberry AM, Balasubramanian S, Lau AG, Hall RA. 2003. Heterodimerization of alpha 2A- and beta 1-adrenergic receptors. J. Biol. Chem. 278:10770-77
108. Gines S, Hillion J, Torvinen M, Le Crom S, Casado V, et al. 2000. Dopamine D1 adenosine Al receptors form functionally interacting heteromeric complexes. Proc. Natl. Acad. Sci. USA 97:8606-11
109. Shieh BH, Stamnes MA, Seavello S, Harris GL, Zuker CS. 1989. The ninaA gene required for visual transduction in Drosophila encodes a homologue of cyclosporin A-binding protein. Nature 338:67-70
110. Schneuwly S, Shortridge RD, Larrivee DC, Ono T, Ozaki M, Pak WL. 1989. Drosophila ninaA gene encodes an eye-specific cyclophilin (cyclosporine A binding protein). Proc. Natl. Acad. Sci. USA 86:5390-94
111. Colley NJ, Baker EK, Stamnes MA, Zuker CS. 1991. The cyclophilin homolog ninaA is required in the secretory pathway. Cell 67:255-63
112. Baker EK, Colley NJ, Zuker CS. 1994. The cyclophilin homolog NinaA functions asa chaperone, forming a stable complex in vivo with its protein target rhodopsin. EMBO J. 113:4886-95
113. Dwyer ND, Troemel ER, Sengupta P, Bargmann CI. 1998. Odorant receptor localization to olfactory cilia is mediated by ODR-4, a novel membrane-associated protein. Cell 93:455-66
114. Murrell JR, Hunter DD. 1999. An olfactory sensory neuron line, odora, properly targets olfactory proteins and responds to odorants. J. Neurosci. 19:8260-70
115. Gimelbrant AA, Haley SL, McClintock TS. 2001. Olfactory receptor trafficking involves conserved regulatory steps. J. Biol. Chem. 276:7285-90
116. McLatchie LM, Fraser NJ, Main MJ, Wise A, Brown J, et al. 1998. RAMPs regulate the transport ligand specificity of the calcitonin-receptor-like receptor. Nature 393:333-39
117. Hilairet S, Foord SM, Marshall FH, Bouvier M. 2001. Protein-protein interaction and not glycosylation determines the binding selectivity of heterodimers between the calcitonin receptor-like receptor and the receptor activity-modifying proteins. J. Biol. Chem. 276:29575-81
118. a. Hilairet S, Belanger C, Bertrand J, Laperriere A, Foord SM, Bouvier M. 2001. Agonist-promoted internalization of a ternary complex between calcitonin receptor-like receptor, receptor activity-modifying protein 1 (CRAMP 1), and beta-arrestin. J. Biol. Chem. 276:42182-90
119. Christopoulos A, Christopoulos G, Morfis M, Udawela M, Laburthe M, et al. 2003. Novel receptor partners function of receptor activity-modifying proteins. J. Biol. Chem. 278:3293-97
120. Uezono Y, Bradley J, Min C, McCarty NA, Quick M, et al. 1993. Receptors that couple to 2 classes of G proteins increase cAMP activate CFTR expressed in Xenopus oocytes. Recept. Channels 1:233-41
121. Evans BN, Rosenblatt MI, Mnayer LO, Oliver KR, Dickerson IM. 2000. CGRPRCP, a novel protein required for signal transduction at calcitonin gene-related peptide and adrenomedullin receptors. J. Biol. Chem. 275:31438-43
122. Prado MA, Evans-Bain B, Oliver KR, Dickerson IM. 2001. The role of the CGRP-receptor component protein (RCP) in adrenomedullin receptor signal transduction. Peptides 22:1773-81
123. Siffroi-Fernandez S, Giraud A, Lanet J, Franc JL. 2002. Association of the thyrotropin receptor with calnexin, calreticulin and BiP. Effects on the maturation of the receptor. Eur. J. Biochem. 269:4930-37
124. Rozell TG, Davis DP, Chai Y, Segaloff DL. 1998. Association of gonadotropin receptor precursors with the protein folding chaperone calnexin. Endocrinology 139:1588-93
125. Ferreira PA, Hom JT, Pak WL. 1995. Retina-specifically expressed novel subtypes of bovine cyclophilin. J. Biol. Chem. 270:23179-88
126. Ferreira PA, Nakayama TA, Pak WL, Travis GH. 1996. Cyclophilin-related protein RanBP2 acts as chaperone for red/green opsin. Nature 383:637-40
127. Chapple JP, Cheetham ME. 2003. The chaperone environment at the cytoplasmic face of the endoplasmic reticulum can modulate rhodopsin processing and inclusion formation. J. Biol. Chem. 278:19087-94
128. Xu Z, Hirasawa A, Shinoura H, Tsujimoto G. 1999. Interaction of the alpha(1B)-adrenergic receptor with gC1q-R, a multifunctional protein. J. Biol. Chem. 274:21149-54
129. Lim BL, Reid KB, Ghebrehiwet B, Peerschke EI, Leigh LA, Preissner KT. 1996. The binding protein for globular heads of complement C1q, gC1qR. Functional expression and characterization as a novel vitronectin binding factor. J. Biol. Chem. 271:26739-44
130. Herwald H, Dedio J, Kellner R, Loos M, Muller-Esterl W. 1996. Isolation and characterization of the kininogen-binding protein p33 from endothelial cells. Identity with the gC1q receptor. J. Biol. Chem. 271:13040-47
131. Altschuler Y, Barbas SM, Terlecky LJ, Tang K, Hardy S, et al. 1998. Redundant distinct functions for dynamin-1 and dynamin-2 isoforms. J. Cell Biol. 143:1871-81
132. a. Michel JJ, Scott JD. 2002. AKAP mediated signal transduction. Annu. Rev. Pharmacol. Toxicol. 42:235-57
133. b. Hung AY, Sheng M. 2002. PDZ domains: structural modules for protein complex assembly. J. Biol. Chem. 277(8):5699-702
134. Smith FD, Oxford GS, Milgram SL. 1999. Association of the D2 dopamine receptor third cytoplasmic loop with spinophilin, a protein phosphatase-1-interacting protein. J. Biol. Chem. 274: 19894-900
135. Richman JG, Brady AE, Wang Q, Hensel JL, Colbran RJ, Limbird LE. 2001. Agonist-regulated interaction between alpha2-adrenergic receptors and spinophilin. J. Biol. Chem. 276:15003-8
136. Allen PB, Ouimet CC, Greengard P. 1997. Spinophilin, a novel protein phosphatase 1 binding protein localized to dendritic spines. Proc. Natl. Acad. Sci. USA 94:9956-61
137. Satoh A, Nakanishi H, Obaishi H, Wada M, Takahashi K, et al. 1998. Neurabin-II/spinophilin. An actin filament-binding protein with one pdz domain localized at cadherin-based cell-cell adhesion sites. J. Biol. Chem. 273:3470-75
138. Edwards SW, Limbird LE. 1999. Role for the third intracellular loop in cell surface stabilization of the alpha2A-adrenergic receptor. J. Biol. Chem. 274:16331-36
139. Brakeman PR, Lanahan AA, O'Brien R, Roche K, Barnes CA, et al. 1997. Homer: a protein that selectively binds metabotropic glutamate receptors. Nature 386:284-88
140. Gertler FB, Niebuhr K, Reinhard M, Wehland J, Soriano P. 1996. Mena, a relative of VASP and Drosophila Enabled, is implicated in the control of microfilament dynamics. Cell 87:227-39
141. Xiao B, Tu JC, Petralia RS, Yuan JP, Doan A, et al. 1998. Homer regulates the association of group 1 metabotropic glutamate receptors with multivalent complexes of homer-related, synaptic proteins. Neuron 21:707-16
142. Tu JC, Xiao B, Yuan JP, Lanahan AA, Leoffert K, et al. 1998. Homer binds a novel proline-rich motif links group 1 metabotropic glutamate receptors with IP3 receptors. Neuron 21:717-26
143. Roche KW, Tu JC, Petralia RS, Xiao B, Wenthold RJ, Worley PF. 1999. Homer lb regulates the trafficking of group I metabotropic glutamate receptors. J. Biol. Chem. 274:25953-57
144. Ciruela F, Soloviev MM, Chan WY, McIlhinney RA. 2000. Homer-1c/Ves1-1L modulates the cell surface targeting of metabotropic glutamate receptor type 1alpha: evidence for an anchoring function. Mol. Cell Neurosci. 15:36-50
145. Ango F, Prezeau L, Muller T, Tu JC, Xiao B, et al. 2001. Agonist-independent activation of metabotropic glutamate receptors by the intracellular protein Homer. Nature 411:962-65
146. Ciruela F, Soloviev MM, McIlhinney RA. 1999. Co-expression of metabotropic glutamate receptor type 1alpha with homer-1a/Ves1-1S increases the cell surface expression of the receptor. Biochem. J. 341:795-803
147. Tu JC, Xiao B, Naisbitt S, Yuan JP, Petralia RS, et al. 1999. Coupling of mGluR/Homer PSD-95 complexes by the Shank family of postsynaptic density proteins. Neuron 23:583-92
148. Gorlin JB, Yamin R, Egan S, Stewart M, Stossel TP, et al. 1990. Human endothelial actin-binding protein (ABP-280, nonmuscle filamin): a molecular leaf spring. J. Cell Biol. 111:1089-105
149. Awata H, Huang C, Handlogten ME, Miller RT. 2001. Interaction of the calcium-sensing receptor and filamin, a potential scaffolding protein. J. Biol. Chem. 276:34871-79
150. Seck T, Baron R, Home WC. 2003. Binding of filamin to the C-terminal tail of the calcitonin receptor controls recycling. J. Biol. Chem. 278:10408-416
151. Walensky LD, Blackshaw S, Liao D, Watkins CC, Weier HU, et al. 1999. A novel neuron-enriched homolog of the erythrocyte membrane cytoskeletal protein 4.1. J. Neurosci. 19:6457-67
152. Shen L, Liang F, Walensky LD, Huganir RL. 2000. Regulation of AMPA receptor GluR1 subunit surface expression by a 4. 1N-linked actin cytoskeletal association. J. Neurosci. 20:7932-40
153. Binda AV, Kabbani N, Lin R, Levenson R. 2002. D2 and D3 dopamine receptor cell surface localization mediated by interaction with protein 4.1N. Mol. Pharmacol. 62:507-13
154. Lin R, Karpa K, Kabbani N, Goldman-Rakic P, Levenson R. 2001. Dopamine D2 and D3 receptors are linked to the actin cytoskeleton via interaction with filamin A. Proc. Natl. Acad. Sci. USA 98:5258-63
155. Xue F, Cooley L. 1993. kelch encodes a component of intercellular bridges in Drosophila egg chambers. Cell 72:681-693
156. Adams JC, Seed B, Lawler J. 1998. Muskelin, a novel intracellular mediator of cell adhesive and cytoskeletal responses to thrombospondin-1. EMBO J. 17:4964-74
157. Hasegawa H, Katoh H, Fujita H, Mori K, Negishi M. 2000. Receptor isoform-specific interaction of prostaglandin EP3 receptor with muskelin. Biochem. Biophys. Res. Commun. 276:350-54
158. Hu LA, Tang Y, Miller WE, Cong M, Lau AG, et al. 2000. Beta 1-adrenergic receptor association with PSD-95. Inhibition of receptor internalization facilitiation of beta 1-adrenergic receptor interaction with N-methyl-D-aspartate receptors. J. Biol. Chem. 275:38659-66
159. Gean PW, Huang CC, Lin JH, Tsai JJ. 1992. Sustained enhancement of NMDA receptor-mediated synaptic potential by isoproterenol in rat amygdalar slices. Brain Res. 594:331-34
160. Huang CC, Tsai JJ, Gean PW. 1993. Enhancement of NMDA receptor-mediated synaptic potential by isoproterenol is blocked by Rp-adenosine 3′,5′-cyclic monophosphothioate. Neurosci. Lett. 161:207-10
161. Raman IM, Tong G, Jahr CE. 1996. Beta-adrenergic regulation of synaptic NMDA receptors by cAMP-dependent protein kinase. Neuron 16:415-21
162. Minakami R, Jinnai N, Sugiyama H. 1997. Phosphorylation and calmodulin binding of the metabotropic glutamate receptor subtype 5 (mGluR5) are antagonistic in vitro. J. Biol. Chem. 272:20291-98
163. Means AR, VanBerkum MF, Bagchi I, Lu KP, Rasmussen CD. 1991. Regulatory functions of calmodulin. Pharmacol. Ther 50:255-70
164. Nakajima Y, Yamamoto T, Nakayama T, Nakanishi S. 1999. A relationship between protein kinase C phosphorylation and calmodulin binding to the metabotropic glutamate receptor subtype 7. J. Biol. Chem. 274:27573-77
165. O'Connor V, El Far O, Bofill-Cardona E, Nanoff C, Freissmuth M, et al. 1999. Calmodulin dependence of presynaptic metabotropic glutamate receptor signaling. Science 286:1180-84
166. Wang D, Sadee W, Quillan JM. 1999. Calmodulin binding to G protein-coupling domain of opioid receptors. J. Biol. Chem. 274:22081-88
167. Wang D, Surratt CK, Sadee W. 2000. Calmodulin regulation of basal and agonist-stimulated G protein coupling by the mu-opioid receptor (OP(3)) in morphine-pretreated cell. J. Neurochem. 75:763-71
168. Wang D, Quillan JM, Winans K, Lucas JL, Sadee W. 2001. Single nucleotide polymorphisms in the human mu opioid receptor gene alter basal G protein coupling and calmodulin binding. J. Biol. Chem. 276:34624-30
169. Rhoads AR, Friedberg F. 1997. Sequence motifs for calmodulin recognition. FASEB J. 11:331-40
170. Bofill-Cardona E, Kudlacek O, Yang Q, Ahorn H, Freissmuth M, Nanoff C. 2000. Binding of calmodulin to the D2-dopamine receptor reduces receptor signaling by arresting the G protein activation switch. J. Biol. Chem. 275:32672-80
171. Becamel C, Alonso G, Galeotti N, Demey E, Jouin P, et al. 2002. Synaptic multiprotein complexes associated with 5-HT(2C) receptors: a proteoinic approach. EMBO J. 21:2332-42
172. Lezcano N, Mrzljak L, Eubanks S, Levenson R, Goldman-Rakic P, Bergson C. 2000. Dual signaling regulated by calcyon, a D1 dopamine receptor interacting protein. Science 287:1660-64
173. Fu H, Subramanian RR, Masters SC. 2000. 14-3-3 proteins: structure, function, and regulation. Annu. Rev. Pharmacol. Toxicol. 40:617-47
174. Xiao B, Smerdon SJ, Jones DH, Dodson GG, Soneji Y, et al. 1995. Structure of a 14-3-3 protein implications for coordination of multiple signalling pathways. Nature 376:188-91
175. Muslin AJ, Xing H. 2000. 14-3-3 proteins: regulation of subcellular localization by molecular interference. Cell Signal. 12:703-9
176. Prezeau L, Richman JG, Edwards SW, Limbird LE. 1999. The zeta isoform of 14-3-3 proteins interacts with the third intracellular loop of different alpha2-adrenergic receptor subtypes. J. Biol. Chem. 274:13462-69
177. Couve A, Kittler JT, Uren JM, Calver AR, Pangalos MN, et al. 2001. Association of GABA(B) receptors members of the 14-3-3 family of signaling proteins. Mol. Cell Neurosci. 17:317-28
178. Wang Q, Limbird LE. 2002. Regulated interactions of the alpha 2A adrenergic receptor with spinophilin, 14-3-3zeta, and arrestin 3. J. Biol. Chem. 277:50589-96
179. Scheer A, Costa T, Fanelli F, De Benedetti PG, Mhaouty-Kodja S, et al. 2000. Mutational analysis of the highly conserved arginine within the Glu/ Asp-Arg-Tyr motif of the alpha(1b)-adrenergic receptor: effects on receptor isomerization activation. Mol. Pharmacol. 57:219-31
180. Ghanouni P, Steenhuis JJ, Farrens DL, Kobilka BK. 2001. Agonist-induced conformational changes in the G-protein-coupling domain of the beta 2 adrenergic receptor. Proc. Natl. Acad. Sci. USA 98:5997-6002
181. Kurose H, Lefkowitz RJ. 1994. Differential desensitization and phosphorylation of three cloned and transfected alpha 2-adrenergic receptor subtypes. J. Biol. Chem. 269:10093-99
182. Alewijnse AE, Timmerman H, Jacobs EH, Smit MJ, Roovers E, et al. 2000. The effect of mutations in the DRY motif on the constitutive activity structural instability of the histamine H(2) receptor. Mol. Pharmacol. 57:890-98
183. Wilson MH, Highfield HA, Limbird LE. 2001. The role of a conserved inter-transmembrane domain interface in regulating alpha(2a)-adrenergic receptor conformational stability and cell-surface remover. Mol. Pharmacol. 59: 929-38
184. Samama P, Cotecchia S, Costa T, Lefkowitz RJ. 1993. A mutation-induced activated state of the beta 2-adrenergic receptor. Extending the ternary complex model. J. Biol. Chem. 268:4625-36
185. Chidiac P, Hebert TE, Viquette M, Dennis M, Bouvier M. 1994. Inverse agonist activity of beta-adrenergic antagonists. Mol. Pharmacol. 45:490-99
186. Grotewiel MS, Sanders-Bush E. 1999. Differences in agonist-independent activity of 5-Ht2A and 5-HT2c receptors revealed by heterologous expression. Naunyn Schmiedebergs Arch. Pharmacol. 359:21-27
187. Berg KA, Cropper JD, Niswender CM, Sanders-Bush E, Emeson RB, Clarke WP. 2001. RNA-editing of the 5-HT(2C) receptor alters agonist-receptor-effector coupling specificity. Br. J. Pharmacol. 134:386-92
188. Clapham DE, Neer EJ. 1993. New roles for G-protein beta gamma-dimers in transmembrane signalling. Nature 365:403-6
189. Barak LS, Oakley RH, Laporte SA, Caron MG. 2001. Constitutive arrestin-mediated desensitization of a human vasopressin receptor mutant associated with nephrogenic diabetes insipidus. Proc. Natl. Acad. Sci. USA 98:93-98
190. Wilson MH, Limbird LE. 2000. Mechanisms regulating the cell surface residence time of the alpha 2A-adrenergic receptor. Biochemistry 39:693-700
191. Pasel K, Schulz A, Timmermann K, Linnemann K, Hoeltzenbein M, et al. 2000. Functional characterization of the molecular defects causing nephrogenic diabetes insipidus in eight families. J. Clin. Endocrinol. Metab. 85:1703-10
192. Ferguson SS. 2001. Evolving concepts in G protein-coupled receptor endocytosis: the role in receptor desensitization signaling. Pharmacol. Rev. 53:1-24
193. von Zastrow M. 2001. Endocytosis downregulation of G protein-coupled receptors. Parkinsonism Relat. Disord. 7:265-71
194. Lefkowitz RJ. 1998. G protein-coupled receptors. III. New roles for receptor kinases beta-arrestins in receptor signaling and desensitization. J. Biol. Chem. 273:18677-80
195. Daaka Y, Luttrell LM, Ahn S, Della RG, Ferguson SS, et al. 1998. Essential role for G protein-coupled receptor endocytosis in the activation of mitogen-activated protein kinase. J. Biol. Chem. 273:685-88
196. DeGraff JL, Gurevich VV, Benovic JL. 2002. The third intracellular loop of alpha 2-adrenergic receptors determines subtype specificity of arrestin interaction. J. Biol. Chem. 277:43247-52
197. Schramm NL, Limbird LE. 1999. Stimulation of mitogen-activated protein kinase by G protein-coupled alpha(2)-adrenergic receptors does not require agonist-elicited endocytosis. J. Biol. Chem. 274:24935-40
198. Shiina T, Nagao T, Kurose H. 2001. Low affinity of beta1-adrenergic receptor for beta-arrestins explains the resistance to agonist-induced internalization. Life Sci. 68:2251-57
199. Vogler O, Krummenerl P, Schmidt M, Jakobs KH, Van Koppen CJ. 1999. RhoA-sensitive trafficking of muscarinic acetylcholine receptors. J. Pharmacol. Exp. Ther. 288:36-42
200. Claing A, Laporte SA, Caron MG, Lefkowitz RJ. 2002. Endocytosis of G protein-coupled receptors: roles of G protein-coupled receptor kinases and beta-arrestin proteins. Prog. Neurobiol. 66:61-79
201. Anderson RG. 1998. The caveolae membrane system. Annu. Rev. Biochem. 67: 199-225
202. Brodsky FM, Chen CY, Knuehl C, Towler MC, Wakeham DE. 2001. Biological basket weaving: formation and function of clathrin-coated vesicles. Annu. Rev. Cell Dev. Biol. 17:517-68
203. Rapacciuolo A, Suvarna S, Barki-Harrington L, Luttrell LM, Cong M, et al. 2003. PKA GRK phosphorylation mediate beta-1 adrenergic receptor endocytosis through different pathways. J. Biol. Chem. See http://www.jbc.org/ cgi/reprint/M305675200v1
204. Marchese A, Benovic JL. 2001. Agonist-promoted ubiquitination of the G protein-coupled receptor CXCR4 mediates lysosomal sorting. J. Biol. Chem. 276:45509-12
205. Shenoy SK, McDonald PH, Kohout TA, Lefkowitz RJ. 2001. Regulation of receptor fate by ubiquitination of activated beta 2-adrenergic receptor and beta-arrestin. Science 294:1307-13
206. Shenoy SK, Lefkowitz RJ. 2003. Trafficking patterns of beta-arrestin and G protein-coupled receptors determined by the kinetics of beta-arrestin deubiquitination. J. Biol. Chem. 278:14498-506
207. Claing A, Perry SI, Achiriloaie M, Walker JK, Albanesi JP, et al. 2000. Multiple endocytic pathways of G protein-coupled receptors delineated by GIT1 sensitivity. Proc. Natl. Acad. Sci. USA 97:1119-24
208. Claing A, Chen W, Miller WE, Vitale N, Moss J, et al. 2001. Beta-arrestin-mediated ADP-ribosylation factor 6 activation beta 2-adrenergic receptor endocytosis. J. Biol. Chem. 276:42509-13
209. Ahn S, Maudsley S, Luttrell LM, Lefkowitz RJ, Daaka Y. 1999. Src-mediated tyrosine phosphorylation of dynamin is required for beta2-adrenergic receptor internalization and mitogen-activated protein kinase signaling. J. Biol. Chem. 274:1185-88
210. Oakley RH, Laporte SA, Holt JA, Caron MG, Barak LS. 2000. Differential affinities of visual arrestin, beta arrestin1, and beta arrestin2 for G protein-coupled receptors delineate two major classes of receptors. J. Biol. Chem. 275:17201-10
211. Krupnick JG, Goodman OB Jr, Keen JH, Benovic JL. 1997. Arrestin/clathrin interaction. Localization of the clathrin binding domain of nonvisual arrestins to the carboxy terminus. J. Biol. Chem. 272:15011-16
212. Krupnick JG, Santini F, Gagnon AW, Keen JH, Benovic JL. 1997. Modulation of the arrestin-clathrin interaction in cells. Characterization of beta-arrestin dominant-negative mutants. J. Biol. Chem. 272:32507-12
213. Laporte SA, Oakley RH, Holt JA, Barak LS, Caron MG. 2000. The interaction of beta-arrestin with the AP-2 adaptor is required for the clustering of beta 2-adrenergic receptor into clathrin-coated pits. J. Biol. Chem. 275:23120-26
214. Chu P, Murray S, Lissin D, von Zastrow M. 1997. Delta and kappa opioid receptors are differentially regulated by dynamin-dependent endocytosis when activated by the same alkaloid agonist. J. Biol. Chem. 272:27124-30
215. Kohout TA, Lin FS, Perry SJ, Conner DA, Lefkowitz RJ. 2001. Beta-arrestin 1 and 2 differentially regulate heptahelical receptor signaling and trafficking. Proc. Natl. Acad. Sci. USA 98:1601-6
216. Bohn LM, Lefkowitz RJ, Gainetdinov RR, Peppel K, Caron MG, Lin FT. 1999. Enhanced morphine analgesia in mice lacking beta-arrestin 2. Science 286:2495-98
217. Bohn LM, Gainetdinov RR, Lin FT, Lefkowitz RJ, Caron MG. 2000. Mu-opioid receptor desensitization by beta-arrestin-2 determines morphine tolerance but not dependence. Nature 408:720-23
218. Ferguson SS, Downey WE III, Colapietro AM, Barak LS, Menard L, Caron MG. 1996. Role of beta-arrestin in mediating agonist-promoted G protein-coupled receptor internalization. Science 271:363-66
219. DeGraff JL, Gagnon AW, Benovic JL, Orsini MJ. 1999. Role of arrestins in endocytosis and signaling of alpha2-adrenergic receptor subtypes. J. Biol. Chem. 274:11253-59
220. Oakley RH, Laporte SA, Holt JA, Barak LS, Caron MG. 1999. Association of beta-arrestin with G protein-coupled receptors during clathrin-mediated endocytosis dictates the profile of receptor resensitization. J. Biol. Chem. 274: 32248-57
221. Orsini MJ, Parent JL, Mundell SJ, Benovic JL, Marchese A. 1999. Trafficking of the HIV coreceptor CXCR4. Role of arrestins and identification of residues in the C-terminal tail that mediate receptor internalization. J. Biol. Chem. 274:31076-86
222. Mundell SJ, Matharu AL, Kelly E, Benovic JL. 2000. Arrestin isoforms dictate differential kinetics of A2B adenosine receptor trafficking. Biochemistry 39:12828-362
223. Li JG, Luo LY, Krupnick JG, Benovic JL, Liu-Chen LY. 1999. U50,488H-induced internalization of the human kappa opioid receptor involves a beta-arrestin- and dynamin-dependent mechanism. Kappa receptor internalization is not required for mitogen-activated protein kinase activation. J. Biol. Chem. 274:12087-94
224. Zhang J, Ferguson SS, Barak LS, Bodduluri SR, Laporte SA, et al. 1998. Role for G protein-coupled receptor kinase in agonist-specific regulation of mu-opioid receptor responsiveness. Proc. Natl. Acad. Sci. USA 95:7157-62
225. Dery O, Thoma MS, Wong H, Grady EF, Bunnett NW. 1999. Trafficking of proteinase-activated receptor-2 and beta-arrestin-1 tagged with green fluorescent protein. Beta-arrestin-dependent endocytosis of a proteinase receptor. J. Biol. Chem. 274:18524-35
226. Braun L, Christophe T, Boulay F. 2003. Phosphorylation of key serine residues is required for internalization of the complement 5a (C5a) anaphylatoxin receptor via a beta-arrestin, dynamin, and clathrin-dependent pathway. J. Biol. Chem. 278:4277-85
227. Kreuzer OJ, Krisch B, Dery O, Bunnett NW, Meyerhof W. 2001. Agonist-mediated endocytosis of rat somatostatin receptor subtype 3 involves beta-arrestin and clathrin coated vesicles. J. Neuroendocrinol. 13:279-87
228. Vrecl M, Anderson L, Hanyaloglu A, McGregor AM, Groarke AD, et al. 1998. Agonist-induced endocytosis recycling of the gonadotropin-releasing hormone receptor: effect of beta-arrestin on internalization kinetics. Mol. Endocrinol. 12:1818-29
229. Oakley RH, Laporte SA, Holt JA, Barak LS, Caron MG. 2001. Molecular determinants underlying the formation of stable intracellular G protein-coupled receptor-beta-arrestin complexes after receptor endocytosis. J. Biol. Chem. 276:19452-60
230. Bhatnagar A, Willins DL, Gray JA, Woods J, Benovic JL, Roth BL. 2001. The dynamin-dependent, arrestin-independent internalization of 5-hydroxytryptamine 2A (5-HT2A) serotonin receptors reveals differential sorting of arrestins and 5-HT2A receptors during endocytosis. J. Biol. Chem. 276:8269-77
231. Smyth EM, Austin SC, Reilly MP, FitzGerald GA. 2000. Internalization and sequestration of the human prostacyclin receptor. J. Biol. Chem. 275:32037-45
232. Zhang J, Ferguson SS, Barak LS, Menard L, Caron MG. 1996. Dynamin and beta-arrestin reveal distinct mechanisms for G protein-coupled receptor internalization. J. Biol. Chem. 271:18302-5
233. Ahn S, Nelson CD, Garrison TR, Miller WE, Lefkowitz RJ. 2003. Desensitization, internalization, and signaling functions of beta-arrestins demonstrated by RNA interference. Proc. Natl. Acad. Sci. USA 100:1740-44
234. Gaborik Z, Szaszak M, Szidonya L, Balla B, Paku S, et al. 2001. Beta-arrestin-dynamin-dependent endocytosis of the AT(1) angiotensin receptor. Mol. Pharmacol. 59:239-47
235. Werbonat Y, Kleutges N, Jakobs KH, Van Koppen CJ. 2000. Essential role of dynamin in internalization of M2 muscarinic acetylcholine and angiotensin AT1A receptors. J. Biol. Chem. 275:21969-74
236. Luttrell LM, Roudabush FL, Choy EW, Miller WE, Field ME, et al. 2001. Activation targeting of extracellular signal-regulated kinases by beta-arrestin scaffolds. Proc. Natl. Acad. Sci. USA 98: 2449-54
237. Tohgo A, Pierce KL, Choy EW, Lefkowitz RJ, Luttrell LM. 2002. Beta-arrestin scaffolding of the ERK cascade enhances cytosolic ERK activity but inhibits ERK-mediated transcription following angiotensin AT1a receptor stimulation. J. Biol. Chem. 277:9429-36
238. DeFea KA, Zalevsky J, Thoma MS, Dery O, Mullins RD, Bunnett NW. 2000. Beta-arrestin-dependent endocytosis of proteinase-activated receptor 2 is required for intracellular targeting of activated ERK 1/2. J. Cell Biol. 148:1267-81
239. McDonald PH, Chow CW, Miller WE, Laporte SA, Field ME, et al. 2000. Beta-arrestin 2: a receptor-regulated MAPK scaffold for the activation of JNK3. Science 290:1574-77
240. McDonald PH, Lefkowitz RJ. 2001. Beta-arrestins: new roles in regulating heptahelical receptors' functions. Cell Signal. 13:683-89
241. Perry SJ, Baillie GS, Kohout TA, McPhee I, Magiera MM, et al. 2002. Targeting of cyclic AMP degradation to beta 2-adrenergic receptors by beta-arrestins. Science 298:834-36
242. Baillie GS, Sood A, McPhee I, Gall I, Perry SJ, et al. 2003. Beta-arrestin-mediated PDE4 cAMP phosphodiesterase recruitment regulates beta-adrenoceptor switching from Gs to Gi. Proc. Natl. Acad. Sci. USA 100:940-45
243. Hall RA, Lefkowitz RJ. 2002. Regulation of G protein-coupled receptor signaling by scaffold proteins. Circ. Res. 91:672-80
244. Luttrell LM, Lefkowitz RJ. 2002. The role of beta-arrestins in the termination and transduction of G-protein-coupled receptor signals. J. Cell Sci. 115:455-65
245. Perry SJ, Lefkowitz RJ. 2002. Arresting developments in heptahelical receptor signaling and regulation. Trends Cell Biol. 12:130-38
246. Pierce KL, Luttrell LM, Lefkowitz RJ. 2001. New mechanisms in heptahelical receptor signaling to mitogen activated protein kinase cascades. Oncogene 20:1532-39
247. Krupnick JG, Benovic JL. 1998. The role of receptor kinases and arrestins in G protein-coupled receptor regulation. Annu. Rev. Pharmacol. Toxicol. 38:289-319
248. Hall RA, Ostedgaard LS, Premont RT, Blitzer JT, Rahman N, et al. 1998. A C-terminal motif found in the beta2-adrenergic receptor, P2Y1 receptor cystic fibrosis transmembrane conductance regulator determines binding to the Na+/H+ exchanger regulatory factor family of PDZ proteins. Proc. Natl. Acad. Sci. USA 95:8496-501
249. Li JG, Chen C, Liu-Chen LY. 2002. Ezrin-radixin-moesin-binding phosphoprotein-50/Na+/H+ exchanger regulatory factor (EBP50/NHERF) blocks U50,488H-induced down-regulation of the human kappa opioid receptor by enhancing its recycling rate. J. Biol. Chem. 277:27545-52
250. Mahon MJ, Donowitz M, Yun CC, Segre GV. 2002. Na(+)/H(+) exchanger regulatory factor 2 directs parathyroid hormone 1 receptor signalling. Nature 417:858-61
251. Hall RA, Premont RT, Chow CW, Blitzer JT, Pitcher JA, et al. 1998. The beta2-adrenergic receptor interacts with the Na+/H+-exchanger regulatory factor to control Na+/H+ exchange. Nature 392:626-30
252. Naren AP, Cobb B, Li C, Roy K, Nelson D, et al. 2003. A macromolecular complex of beta 2 adrenergic receptor, CFTR, ezrin/radixin/moesin-binding phosphoprotein 50 is regulated by PKA. Proc. Natl. Acad. Sci. USA 100:342-46
253. Kurashima K, Yu FH, Cabado AG, Szabo EZ, Grinstein S, Orlowski J. 1997. Identification of sites required for down-regulation of Na+/H+ exchanger NHE3 activity by cAMP-dependent protein kinase, phosphorylation-dependent and -independent mechanisms. J. Biol. Chem. 272:28672-79
254. Cao TT, Deacon HW, Reczek D, Bretscher A, von Zastrow M. 1999. A kinase-regulated PDZ-domain interaction controls endocytic sorting of the beta2-adrenergic receptor. Nature 401:286-90
255. Gage RM, Kim KA, Cao TT, von Zastrow M. 2001. A transplantable sorting signal that is sufficient to mediate rapid recycling of G protein-coupled receptors. J. Biol. Chem. 276:44712-20
256. Lin RC, Scheller RH. 2000. Mechanisms of synaptic vesicle exocytosis. Annu. Rev. Cell Dev. Biol. 16:19-49
257. Brunger AT. 2000. Structural insights into the molecular mechanism of Ca(2+)-dependent exocytosis. Curr. Opin. Neurobiol. 10:293-302
258. Cong M, Perry SJ, Hu LA, Hanson PI, Claing A, Lefkowitz RJ. 2001. Binding of the beta2 adrenergic receptor to N-ethylmaleimide-sensitive factor regulates receptor recycling. J. Biol. Chem. 276:45145-52
259. Morello JP, Bichet DG. 2001. Nephrogenic diabetes insipidus. Annu. Rev. Physiol. 63:607-30
260. Morello JP, Salahpour A, Petaja-Repo UE, Laperriere A, Lonergan M, et al. 2001. Association of calnexin with wild type mutant AVPR2 that cause nephrogenic diabetes insipidus. Biochemistry 40:6766-75
261. Yun J, Schoneberg T, Liu J, Schulz A, Ecelbarger CA, et al. 2000. Generation phenotype of mice harboring a nonsense mutation in the V2 vasopressin receptor gene. J. Clin. Invest. 106:1361-71
262. Morello JP, Salahpour A, Laperriere A, Bernier V, Arthus MF, et al. 2000. Pharmacological chaperones rescue cell-surface expression function of misfolded V2 vasopressin receptor mutants. J. Clin. Invest. 105:887-95
263. Tan CM, Nickols HH, Limbird LE. 2003. Appropriate polarization following pharmacological rescue of V2 vasopressin receptors encoded by X-linked nephrogenic diabetes insipidus alleles involves a conformation of the receptor that also attains mature glycosylation. J. Biol. Chem. See http://www.jbc. org/cgi/reprint/M301888200v1
264. Denning GM, Anderson MP, Amara JF, Marshall J, Smith AE, Welsh MJ. 1992. Processing of mutant cystic fibrosis transmembrane conductance regulator is temperature-sensitive. Nature 358:761-64
265. Burrows JA, Willis LK, Perlmutter DH. 2000. Chemical chaperones mediate increased secretion of mutant alpha 1-antitrypsin (alpha 1-AT) Z: a potential pharmacological strategy for prevention of liver injury and emphysema in alpha 1-AT deficiency. Proc. Natl. Acad. Sci USA 97:1796-801
266. Zhou Z, Gong Q, January CT. 1999. Correction of defective protein trafficking of a mutant HERG potassium channel in human long QT syndrome. Pharmacological and temperature effects. J. Biol. Chem. 274:31123-26
267. Liang Y, Fotiadis D, Filipek S, Saperstein DA, Palczewski K, Engel A. 2003. Organization of the G protein-coupled receptors rhodopsin and opsin in native membranes. J. Biol. Chem. 278:216555-62
268. Fotiadis D, Liang Y, Filipek S, Saperstein DA, Engel A, Palczewski K. 2003. Atomic-force microscopy: rhodopsin dimers in native disc membranes. Nature 421:127-28
269. Meng EC, Bourne HR. 2001. Receptor activation: what does the rhodopsin structure tell us? Trends Pharmacol. Sci. 22:587-93
270. Dejneka NS, Bennett J. 2001. Gene therapy and retinitis pigmentosa: advances and future challenges. BioEssays 23:662-68
271. Sung CH, Davenport CM, Hennessey JC, Maumenee IH, Jacobson SG, et al. 1991. Rhodopsin mutations in autosomal dominant retinitis pigmentosa. Proc. Natl. Acad. Sci. USA 88:6481-85
272. Sung CH, Makino C, Baylor D, Nathans J. 1994. A rhodopsin gene mutation responsible for autosomal dominant retinitis pigmentosa results in a protein that is defective in localization to the photoreceptor outer segment. J. Neurosci. 14:5818-33
273. Tam BM, Moritz OL, Hurd LB, Papermaster DS. 2000. Identification of an outer segment targeting signal in the COOH terminus of rhodopsin using transgenic Xenopus laevis. J. Cell Biol. 151:1369-80
274. Garriga P, Liu X, Khorana HG. 1996. Structure and function in rhodopsin: correct folding and misfolding in point mutants at and in proximity to the site of the retinitis pigmentosa mutation Leu-125 → Arg in the transmembrane helix C. Proc. Natl. Acad. Sci. USA 93:4560-64
275. Anukanth A, Khorana HG. 1994. Structure and function in rhodopsin. Requirements of a specific structure for the intradiscal domain. J. Biol. Chem. 269:19738-44
276. Noorwez SM, Kuksa V, Imanishi Y, Zhu L, Filipek S, et al. 2003. Pharmacological chaperone-mediated in vivo folding stabilization of the P23H-opsin mutant associated with autosomal dominant retinitis pigmentosa. J. Biol. Chem. 278:14442-50
277. Choo-Kang LR, Zeitlin PL. 2001. Induction of HSP70 promotes DeltaF508 CFTR trafficking. Am. J. Physiol Lung Cell Mol. Physiol. 281:L58-68
278. Maya-Nunez G, Janovick JA, Ulloa-Aguirre A, Soderlund D, Conn PM, Mendez JP. 2002. Molecular basis of hypogonadotropic hypogonadism: restoration of mutant (E(90)K) GnRH receptor function by a deletion at a distant site. J. Clin. Endocrinol. Metab 87:2144-49
279. Cornea A, Janovick JA, Maya-Nunez G, Conn PM. 2001. Gonadotropin-releasing hormone receptor microaggregation. Rate monitored by fluorescence resonance energy transfer. J. Biol. Chem. 276:2153-58
280. Lin X, Janovick JA, Brothers S, Blomenrohr M, Bogerd J, Conn PM. 1998. Addition of catfish gonadotropin-releasing hormone (GnRH) receptor intracellular carboxyl-terminal tail to rat GnRH receptor alters receptor expression and regulation. Mol. Endocrinol. 12:161-71
281. Leanos-Miranda A, Janovick JA, Conn PM. 2002. Receptor-misrouting: an unexpectedly prevalent and rescuable etiology in gonadotropin-releasing hormone receptor-mediated hypogonadotropic hypogonadism. J. Clin. Endocrinol. Metab. 87:4825-28
282. Janovick JA, Maya-Nunez G, Conn PM. 2002. Rescue of hypogonadotropic hypogonadism-causing and manufactured GnRH receptor mutants by a specific protein-folding template: misrouted proteins as a novel disease etiology and therapeutic target. J. Clin. Endocrinol. Metab. 87:3255-62
283. Janovick JA, Goulet M, Bush E, Greer J, Wettlaufer DG, Conn PM. 2003. Structure-activity relations of successful pharmacologic chaperones for rescue of naturally occurring and manufactured mutants of the gonadotropin-releasing hormone receptor. J. Pharmacol. Exp. Ther. 305:608-14